In infertile men, it is hypothesized that cases with elevated seminal OS may benefit from AOX therapy
One newer option being studied is cagrilintide, an investigational injectable developed by Novo Nordisk, the same company behind Ozempic and Wegovy
2009 Nazzareno Ballatori, Suzanne M Krance, Sylvia Notenboom, Shujie Shi, Kim Tieu, Christine L Hammond
Note: Originally published in December 2018, this article has been revised and updated for accuracy and thoroughness.
Additionally, body mass index (BMI) was identified as an effect modifier, demonstrating a significant negative interaction ( = 0.021, 95% CI -0.032 to 0.010) between serum vitamin B12 and testosterone in women aged 20 to 39 years
At nearly 5000 Da, it approaches the upper limit of what intranasal delivery can effectively handle